3/2/12 Contest Update
There was little leaping by stocks during Leap Year week, with investors being more content to yelp rather than roar. At Friday’s close, the Contest median was up 21.84% YTD (vs. up 22.75% YTD a week ago). In comparison, the Nasdaq Biotech Index was up 14.81% YTD (vs. up 14.39% YTD a week ago), while the Nasdaq Composite Index was up 14.24% YTD (vs. up 13.77% YTD a week ago).
GENE’s portfolio, up 41.59% YTD, held on to first place, with BIOJIM’s portfolio, up 38.63% YTD, remaining in second place and ROBERT’s portfolio, up 38.27% YTD, a smidgen behind in third place.
At Friday's close, all 38 Contest portfolios were still in the black, with 23 of the 38 portfolios doing better than the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
(Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables.)
Portfolio adjustments: None
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
3/2/12
Rank Name Profit/Loss
1 GENE 41,589
2 BIOJIM 38,629
3 ROBERT 38,273
4 RKRW 32,778
5 SCARAM 31,994
6 ARTHUR 31,965
7 PGO 30,863
8 BIOMAV 30,408
9 DONS 29,439
10 BIOFISH 26,974
Week's Top 5 Gainers
Symbol 2/24/12 3/2/12 Wk. % chg.
TTHI 1.70 1.90 11.76%
GLPG.BR 11.62 12.92 11.19%
PBTH 5.44 6.04 11.03%
NKTR 6.98 7.67 9.89%
RGEN 4.29 4.69 9.32%
Week's Top 5 Losers
Symbol 2/24/12 3/2/12 Wk. % chg.
DNDN 14.86 11.14 -25.03%
THLD 6.08 4.82 -20.72%
AMRS 6.00 4.90 -18.33%
OPXA 1.03 0.88 -14.58%
SNTA 5.18 4.45 -14.09% |
